Eduard Vieta
Bipolar Disorders · 2003–2021
A researcher in the Science corpus: 18 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Eduard Vieta trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Eduard Vieta's perspective
Ordered by how strongly the researchers Eduard Vieta trusts endorse each paper. Same corpus, a different order for every researcher.
- Effectiveness of adjunctive antidepressant treatment for bipolar depression. (New England Journal of Medicine)
- The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. (Journal of Affective Disorders)
- The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data (Brain Imaging and Behavior)
- Memory and the brain. (Journal of Dental Education)
- The positive and negative syndrome scale (PANSS) for schizophrenia.
- Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
- A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. (Archives of General Psychiatry)
- Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. (Journal of Clinical Psychiatry)
- PSYCHOMETRIC PROPERTIES OF A NORWEGIAN RESEARCH VERSION OF THE 'WECHSLER ABBREVIATED SCALE OF INTELLIGENCE' (WASI)
- The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. (American Journal of Psychiatry)
Their papers
- How mental health care should change as a consequence of the COVID-19 pandemic (2020) — 1,286 citations
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (2021) — 613 citations
- Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) — 994 citations
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. (2019) — 642 citations
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018) — 1,572 citations
- Genomic dissection of bipolar disorder and schizophrenia including 28 subphenotypes (2018) — 667 citations
- Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group (2017) — 708 citations
- The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders (2013) — 664 citations
- Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis (2013) — 604 citations
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. (2009) — 631 citations
- Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology (2009) — 952 citations
- Functional outcome in bipolar disorder: the role of clinical and cognitive factors. (2007) — 603 citations
- Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder (2007) — 854 citations
- The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. (2005) — 682 citations
- Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. (2004) — 1,151 citations
- Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. (2004) — 630 citations
- Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. (2003) — 854 citations
- A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. (2003) — 767 citations